ONCY Oncolytics Biotech Inc.

NASDAQ
$0.68

Oncolytics Biotech Inc. (ONCY) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $0.06 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -14.9% since its last earnings release on August 12, 2026.

Oncolytics Biotech Missed Consensus Estimates
Wednesday, August 12, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · Before Open
Earnings Whisper
-
vs ($0.06)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.79

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.